You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myelosuppression

Showing 26 - 50 of 469
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Chemo-Induced Myelosuppression Trial (Careseng 1370, Placebo)

Withdrawn
  • Chemotherapy-Induced Myelosuppression
  • Careseng 1370
  • Placebo
  • (no location specified)
Dec 13, 2018

Prostate Cancer Trial in Germany (Cyclophosphamide (Non-IMP), Fludarabine (Non-IMP), UniCAR02-T-pPSMA)

Recruiting
  • Prostate Cancer
  • Cyclophosphamide (Non-IMP)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +3 more
Jan 24, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Niraparib in Patients With Ovarian Cancer in Clinical Practice

Recruiting
  • Ovarian Cancer
  • Tokyo, Japan
    Takeda Selected Site
Oct 21, 2022

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

Not yet recruiting
  • Advanced Squamous Non-Small-Cell Lung Cancer
  • (no location specified)
Jun 11, 2023

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Special Drug Use-results Surveillance of Scemblix Tablets

Recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • Toyohashi, Aichi, Japan
  • +24 more
Aug 10, 2022

Cytomegalovirus Retinitis, HIV Trial in Los Angeles, San Francisco, New York (Foscarnet sodium)

Completed
  • Cytomegalovirus Retinitis
  • HIV Infections
  • Foscarnet sodium
  • Los Angeles, California
  • +4 more
Oct 27, 2021

HIV Trial in United States (Zidovudine, Zalcitabine, Didanosine)

Completed
  • HIV Infections
  • San Francisco, California
  • +15 more
Oct 28, 2021

Ovarian Cancer Trial in Maywood (Minoxidil)

Recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Jun 23, 2022

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

Recruiting
  • Bortezomib
  • Acute Myeloid Leukemia
  • DAG pre-excitation regimen with Bortezomib
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

Not yet recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
May 26, 2022

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)

Not yet recruiting
  • Vitamin D Deficiency
  • Peripheral Neuropathy
  • Vitamin D
  • (no location specified)
May 2, 2023

PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

Unknown status
  • Chemotherapy-induced Neutropenia
  • Myelosuppression
  • (no location specified)
Feb 18, 2019

Toxicity Due to Radiotherapy, NSCLC Trial in Hefei (High-dose fractionated radiotherapy, Low-dose fractionated radiotherapy)

Recruiting
  • Toxicity Due to Radiotherapy
  • Non-small Cell Lung Cancer
  • High-dose fractionated radiotherapy
  • Low-dose fractionated radiotherapy
  • Hefei, Anhui, China
    Anhui Provicial Hospital
Mar 7, 2022

CAEBV Trial in Beijing (Selinexol and Dexamethasone)

Not yet recruiting
  • CAEBV
  • Selinexol and Dexamethasone
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 21, 2022

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • (no location specified)
Jul 28, 2022

HLH Trial in Beijing (Zanubrutinib)

Recruiting
  • HLH
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 2, 2022